Chrome Extension
WeChat Mini Program
Use on ChatGLM

Efficacité du rituximab dans la myasthénie auto-immune : à propos d’un cas et revue de la littérature

J. Corriger, M. Cabon, T. Moulinet, L. Charbit, S. Mohamed, J. Deibener, P. Kaminsky

La Revue de Médecine Interne(2014)

Cited 0|Views6
No score
Abstract
a 42-year-old man presented with bilateral longitudinally extensive optic neuritis, associated with longitudinally extensive hyperintensity ranging from cervical to thoracic spinal cord. Anti-MOG and Anti-AQP4 antibodies were negative, as well as IgG and IgM antibodies against SARS-CoV-2. The patient showed dramatic recovery after 5 days of high dose intravenous methylprednisolone.Vaccination is imperative, but clinicians should be aware of its potential adverse events, particularly when immediate treatment can avoid debilitating consequences. Considering the speed up approval processes of vaccines against SARS-CoV-2, permanent pharmacovigilance of severe adverse events in the real world is a paramount.
More
Translated text
Key words
rituximab,auto-immune
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined